NYSEAMERICAN:NSPR - InspireMD Stock Price, Forecast & News

InspireMD trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "NSPR."

InspireMD shares reverse split on the morning of Monday, April 1st 2019. The 1-50 reverse split was announced on Tuesday, March 26th 2019. The number of shares owned by shareholders was adjusted after the closing bell on Friday, March 29th 2019. An investor that had 100 shares of InspireMD stock prior to the reverse split would have 2 shares after the split.

InspireMD Inc (NYSEAMERICAN:NSPR) posted its earnings results on Monday, August, 6th. The medical equipment provider reported ($7.50) EPS for the quarter. The medical equipment provider had revenue of $1 million for the quarter. View InspireMD's Earnings History.

InspireMD is scheduled to release their next quarterly earnings announcement on Tuesday, February 25th 2020. View Earnings Estimates for InspireMD.

InspireMD issued an update on its fourth quarter 2019 Pre-Market earnings guidance on Monday, January, 6th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $1-1.025 million, compared to the consensus revenue estimate of $1.6 million.

1 analysts have issued 1-year target prices for InspireMD's stock. Their forecasts range from $5.00 to $5.00. On average, they expect InspireMD's share price to reach $5.00 in the next year. This suggests a possible upside of 342.4% from the stock's current price. View Analyst Price Targets for InspireMD.

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for InspireMD in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for InspireMD.

News headlines about NSPR stock have trended somewhat positive this week, InfoTrie Sentiment reports. InfoTrie scores the sentiment of media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. InspireMD earned a news sentiment score of 2.0 on InfoTrie's scale. They also gave media coverage about the medical equipment provider a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the next few days. View News Stories for InspireMD.

InspireMD saw a decline in short interest in January. As of January 31st, there was short interest totalling 98,900 shares, a decline of 6.2% from the January 15th total of 105,400 shares. Based on an average trading volume of 331,300 shares, the short-interest ratio is presently 0.3 days. Approximately 8.0% of the company's stock are short sold. View InspireMD's Current Options Chain.

Some companies that are related to InspireMD include LiDCO Group (LID), Deltex Medical Group (DEMG), Zecotek Photonics (ZMS), Lucid (LCDX), MCP Income Opp Trust Ordinary Units FP (MOT) and Verisante Technology (VRS).

Based on aggregate information from My MarketBeat watchlists, some companies that other InspireMD investors own include Palatin Technologies (PTN), TransEnterix (TRXC), Catalyst Pharmaceuticals (CPRX), Inovio Pharmaceuticals (INO), NovaBay Pharmaceuticals (NBY), Novavax (NVAX), AVEO Pharmaceuticals (AVEO), Curis (CRIS), Rexahn Pharmaceuticals (REXN) and Verastem (VSTM).

InspireMD's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Wedbush Securities Inc. (1.67%) and Barclays PLC (0.78%). Company insiders that own InspireMD stock include Paul Stuka and Thomas J Kester. View Institutional Ownership Trends for InspireMD.

NSPR stock was bought by a variety of institutional investors in the last quarter, including Wedbush Securities Inc. and Barclays PLC. View Insider Buying and Selling for InspireMD.

Shares of NSPR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of NSPR stock can currently be purchased for approximately $1.13.

InspireMD has a market capitalization of $4.10 million. InspireMD employs 43 workers across the globe.View Additional Information About InspireMD.

The official website for InspireMD is http://www.inspiremd.com/.

InspireMD's mailing address is 4 Menorat Hamaor St., TEL AVIV-YAFO, MA 6744832, Israel. The medical equipment provider can be reached via phone at +1-857-4536553.